PsyIndex Weekly Update: 6/29 – 7/2


Ryan Allway

July 6th, 2020

Psychedelics


The PsyIndex rose 9.2% last week after a turbulent week prior. At least three privately-held psychedelic companies—Entheon Biomedical, Mindset Pharma and Cybin—announced reverse merger transactions to become publicly-traded.

Market Performance

PsyIndex Weekly Performance: $97.39 (+9.2%)

Top Gainers

  • Revive Therapeutics Ltd.
    +59.39%
    (CSE: RVV) (OTC: RVVTF)
     
  • Empower Clinics Inc.
    +24.21%
    (CSE: CBDT) (OTC: EPWCF)
     
  • Numinus Wellness Inc.
    23.88%
    (TSX-V: NUMI)
Top Decliners

  • New Wave Holdings Inc.
    – 11.23%
    (CSE: SPOR) (OTC: TRMNF)
     
  • Yield Growth Corp.
    -3.48%
    (CSE: BOSS) (OTC: BOSQF)
     
  • Mydecine Innovations Inc.
    -2.98%
    (CSE: MYCO) (OTC: MYCOF

Corporate Developments

  • Cybin Corp. announced a reverse-takeover transaction with Clarmin Explorations Inc. (TSX.V: CX) and a concurrent private placement of up to $21 million. To date, Cybin has raised approximately $10,400,000 through an initial financing round and its series A financing round.
     
  • Entheon Biomedical Corp. announced a definitive agreement for a reverse-takeover with MPV Exploration Inc. (CSE: MPV) and a concurrent financing of at least C$2 million.
     
  • Mindset Pharma Inc. announced a reverse-takeover transaction with North Sur Resources (CSE: H) along with a private placement to raise up to $1 million.
     
  • Field Trip Psychedelics Inc. launched a program called Field Trip Basecamp that will focus on serving individuals suffering from debilitating mental health issues as a result of high-pressure occupations.
     
  • MindMed Inc. has officially launched Project Lucy, a commercial drug development program for the treatment of anxiety disorders.

Industry Developments

  • The Oregon Psilocybin Therapy Initiative announced last week that it has received the necessary amount of signatures for the measure to appear on the ballot—marking another step toward legalization in November. via The Hill

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading